SOURCES
2.5TB CORPUS
The most comprehensive AI product
Each answer cites up to 1,000 documents from 30 regulatory and clinical datasets you trust across 6 markets.
BACKED BYYCOMBINATOR
Know what the
FDA thinks
Instantly answer each regulatory question referencing up to 1,000 documents from public health authority databases without hallucinations.
2,800+Questions
Answered
Answered
20+Customers
C
Which BLAs have used RWE in the
last 5 years?
Answer
Datasets
Sources
Comprehensive and
hallucination-free research
ANSWER
DATASETS
More trustworthy than anything else
We had no hallucinations reported in 2025. Our fine tuning, grounding, and inference-time checks keep them at bay.
SOURCE VIEWER
SOURCE 1 OF 3
p. 17
2.2 RWE Considerations in Labeling Decisions
FDA may consider RWE as supportive evidence when data sources are reliable and protocols are pre-specified.
Inthissubmission,theAgencynotedthatexternalcontroldatasupportedcontextbutwasnotsufficientasprimaryevidenceforefficacyclaims.
Easy fact checking
Each statement has a citation. Each citation jumps directly to a specific page from an authoritative source.
Leveraged by large pharma,
independent consultants, and everyone in between
"Last time we did this research, we spent weeks. Rhizome found the answer immediately."
VP of Regulatory AffairsClinical-Stage Biotech
"Chetan idk what kind of magic you all did here, it's so good!"
VP of Regulatory AffairsCommercial Biotech
Simple, transparent pricing
scale your research with confidence
Professional
$400/mo
Best-value single-seat access
- All of our FDA premarket, postmarket databases
- All of our EMA datasets: EPARs, Guidelines, CTIS, etc.
- Guidance, clinical trials, and SBOAs for 4 other regions
- Pay with a credit card
Best Value
Business
$3,500/yr
Scale your research
- All of our FDA premarket, postmarket databases
- All of our EMA datasets: EPARs, Guidelines, CTIS, etc.
- Guidance, clinical trials, and SBOAs for 4 other regions
- Pay with a credit card
Enterprise
$20,000/yr
Comprehensive global access
- Annual access for 5 seats
- All of our professional-tier databases
- Monthly office hours
- Invoice-based pricing
Custom
Custom
Scale flexibly with your team
- Annual access for 5 seats
- All business-tier benefits
- All regulatory, clinical DBs in South Korea, China, Japan
- Biweekly office hours
Frequently Asked Questions
Everything you need to know about the product.
Our system is built on a hallucination-free architecture. Every single statement in a response is directly grounded in and cited against our 2.5TB corpus of verified FDA, EMA, and global regulatory documents. We cross-verify claims in real-time during inference to ensure unparalleled accuracy.
We sync with primary global regulatory sources (FDA, EMA, PMDA, NMPA, etc.) on a daily basis. New guidance documents, clinical trial data, and warning letters are typically indexed and available within 24 hours of their official publication.
Absolutely not. We maintain a strict zero-retention policy for enterprise queries. Your private documents, search history, and prompts are sandboxed, encrypted at rest, and never utilized to fine-tune our foundational or shared models.
Yes. Enterprise customers can connect their internal Quality Management Systems (QMS), past regulatory submissions, and clinical study reports into a private, isolated silo. The AI will securely search across both our global public corpus and your secure private documents concurrently.